Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis

被引：0
|
作者：
James Patrick Finnerty
Aravind Ponnuswamy
Prosjenjit Dutta
Ammar Abdelaziz
Hafiz Kamil
机构：
[1] Countess of Chester Hospital NHS Trust,Department of Respiratory Medicine
[2] University of Chester Medical School,undefined
[3] The Walton Centre,undefined
来源：
BMC Pulmonary Medicine | / 21卷
关键词：
Idiopathic pulmonary fibrosis; Nintedanib; Pirfenidone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Predicting Mortality in Idiopathic Pulmonary Fibrosis (IPF) Patients Treated with Nintedanib
    Tang, W.
    Menjoge, S.
    Stowasser, S.
    Korell, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [42] South-West of England's Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
    Barratt, Shaney L.
    Mulholland, Sarah
    Al Jbour, Khaled
    Steer, Henry
    Gutsche, Markus
    Foley, Noeleen
    Srivastava, Rajiv
    Sharp, Charles
    Adamali, Huzaifa I.
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [43] Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis
    Rajchgot, Jason
    Stanbrook, Matthew B.
    Anand, Anju
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (08) : 1105 - 1105
  • [44] Efficacy of N-acetylcysteine plus pirfenidone in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
    Zhang, Xiu-Li
    Cao, Ying
    Zheng, Bo
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [45] Efficacy of N-acetylcysteine plus pirfenidone in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
    Xiu-Li Zhang
    Ying Cao
    Bo Zheng
    BMC Pulmonary Medicine, 23
  • [46] Safety and tolerability of combination treatment with pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis: a systemic review and meta-analysis
    Lee, Jonghoo
    Song, Jae-Uk
    JOURNAL OF THORACIC DISEASE, 2023, 15 (11) : 5913 - +
  • [47] Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF)
    Saito, Shigeki
    Alkhatib, Ala
    Kolls, Jay K.
    Kondoh, Yasuhiro
    Lasky, Joseph A.
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S1740 - S1754
  • [48] Late Breaking Abstract - Safety of combined pirfenidone (PFD) and nintedanib (NIN) in patients with idiopathic pulmonary fibrosis (IPF)
    Flaherty, Kevin
    Fell, Charlene D.
    Huggins, J. Terrill
    Nunes, Hilario
    Sussman, Robert
    Valenzuela, Claudia
    Petzinger, Ute
    Stauffer, John. L.
    Gilberg, Frank
    Bengus, Monica
    Wijsenbeek, Marlies
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [49] PATIENT STORIES: THE USE OF NOVEL ANTI-FIBROTICS, PIRFENIDONE AND NINTEDANIB, IN THE MANAGEMENT OF IDIOPATHIC PULMONARY FIBROSIS, IPF
    Enston-Newall, S.
    THORAX, 2017, 72 : A247 - A248
  • [50] Efficacy and Safety of Nintedanib in US and Non-US Patients With Idiopathic Pulmonary Fibrosis (IPF) in the INPULSIS Trials
    Huggins, John
    Kaye, Mitchell
    Bailes, Zelie
    Esser, Dirk
    Conoscenti, Craig
    Flaherty, Kevin
    CHEST, 2015, 148 (04)
12345